Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases.
Liberty University
7 followers
Dyno Therapeutics
4 followers
Cellares
4 followers
Gilead Sciences
161 followers
Regeneron
132 followers
Illumina
79 followers
Agilent Technologies
82 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
45 followers
GRAIL
29 followers
Springside Chestnut Hill Academy
35 followers
Explore companies